Mangalam Drugs and Organics Ltd
NSE: MANGALAM BSE: 532637
₹29.08
(-2.97%)
Wed, 11 Mar 2026, 01:26 am
Market Cap465.35M
PE Ratio0
Dividend0
Health Technology
Pharmaceuticals: Major
24.5KCompany History
1972
- The company was promoted by Dhoot family as Advent Pharma Private Limited.
1977
- The first plant for manufacture of perfumery chemicals at Plot No. 187, GIDC, Vapi was started under the name Advent Pharma Pvt. Ltd.
1981
- A new plant was commissioned under the name Mangalam Rasayan Pvt. Ltd. for manufacture of Anhydrous Aluminium Chloride.
1984
- A new plant was commissioned under the name Shree Mangalam Pharma Pvt. Ltd. for manufacture of Aromatic Chemicals.
- The facilities in APPL were re-organised to manufacture the first Bulk Drug, Metronidazole I.P.
1985
- The capacity of Anhydrous Aluminium Chloride was doubled.
1987
- Inorganic chemicals manufacturing capacities were expanded by putting up a new plant at Sangamner under the name Mangalam Inorganics Pvt. Ltd.
1989
- A new plant was erected to manufacture Dyes Intermediates at Plot No. 1203, IIIrd Phase, GIDC, Vapi under the name Mangalam Organics Private Ltd.
1991
- Additional manufacturing capacity for perfumery chemicals was created under a new plant of SMPPL.
1994
- A new plant was commissioned for manufacturing Meta Chloro Aniline under MRPL.
1996
- Three group companies, Mangalam Organics Private Limited, Shree Mangalam Pharma Private Limited and Mangalam Rasayan Private Limited, were merged with Advent Pharma Private Limited.
1997
- A scheme of arrangement was implemented between SMPPL, MOPL and MRPL, transferring their entire Chemical Division to Mangalam Drugs & Organics Ltd.
- The company became a deemed public limited company.
1999
- A new product, Nimesulide, was launched from Plant at Plot No. 1203.
2001
- Two new products, Amodiaquine Hydrochloride and Amodiaquine, were launched from Plant at Plot No.1203.
- The company was converted into a full-fledged public limited company.
2002
- WHO-GMP approval was received for Chloroquine Phosphate I.P./B.P.
- The company was awarded ISO-9000-2000 Management System Certificate from DNV.
2003
- WHO-GMP approval was received for Amodiaquine Hydrochloride and Amodiaquine U.S.P.
- The company was awarded ISO-9000-2000 Management System Certificate from DNV.
2005
- Mangalam Drugs and Organics Ltd filed a prospectus with Securities Exchange Board of India to raise Rs 14.3 crore through a public issue.
- Shares of Mangalam Drugs & Organics Ltd made their debut on the Bombay Stock Exchange at Rs 30.
2006
- The Company recommended a Final Dividend of Re 0.20 ps (2%) per Equity Share.
2009
- Mr. Mukul Sukhani was appointed as Additional Director on the Board of the Company.
2014
- Mrs Meenal Sukhani was appointed as Additional Director on the Board of the Company.
- The registered office of the company was shifted from Princess Street Near Flyover Bridge, Marine Lines, Mumbai to 3rd Floor, Rupam Building, 237, P. D. Mello Road, Mumbai - 400001, Maharashtra.
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Calculators
Popular Calculators
Group Stocks
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800